Bliss Gvs Pharma Profit & Loss Annual

Trade
BSE: 506197 | NSE: BLISSGVS | ISIN: INE416D01022 | Sector: Biotechnology & Drugs
132.25 +0.75 (0.57%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 770.24751.59747.45577.21
Total Revenue 770.24751.59747.45577.21
Costof Revenue Total 382.12408.45399.23337.05
Gross Profit 388.13343.14348.22240.15
Selling/ General/ Admin Expenses Total 95.58183.25174.96114.93
Depreciation/ Amortization 26.3818.6717.3317.23
Unusual Expense( Income) 29.200.0073.830.00
Other Operating Expenses Total 141.9220.7833.318.15
Total Operating Expense 675.20652.94720.04487.76
Operating Income 95.0598.6527.4289.45
Interest Inc( Exp) Net- Non- Op Total -69.1254.10263.33156.28
Other Net 28.741.650.35-0.92
Net Income Before Taxes 116.87106.0754.17104.13
Provisionfor Income Taxes 35.2929.3431.0430.16
Net Income After Taxes 81.5876.7323.1373.97
Minority Interest -6.12-5.88-8.09-5.48
Net Income Before Extra Items 75.4570.8615.0468.49
Net Income 75.4570.8615.0468.49
Income Availableto Com Excl Extra Ord 75.4570.8615.0468.49
Income Availableto Com Incl Extra Ord 75.4570.8615.0468.49
Diluted Net Income 75.4570.8615.0468.49
Diluted Weighted Average Shares 10.6110.5510.5210.55
Diluted EPS Excluding Extra Ord Items 7.116.721.436.49
DPS- Common Stock Primary Issue 0.500.500.500.50
Diluted Normalized EPS 9.036.694.426.50
Research Development -217.89213.80104.01
Interest Exp( Inc) Net- Operating Total -0.020.020.02
Gain( Loss)on Saleof Assets -3.650.68-0.31
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts